https://news.medxy.ai/zh/blood-pressure-variability-risk/Medxy AIzh2026-04-05T15:18:23-07:00血压变异性成为1型糖尿病肾病进展的独立预测因素，非洲加勒比族裔是关键风险因素 https://news.medxy.ai/ja/blood-pressure-variability-type-1-diabetes/Medxy AIja2026-04-05T15:17:20-07:001型糖尿病における血圧変動が腎臓病進行の独立予測因子として浮上、アフリカ・カリブ海系民族が重要なリスク要因 https://news.medxy.ai/vi/blood-pressure-variability-diabetes/Medxy AIvi2026-04-05T15:15:54-07:00Sự biến động huyết áp nổi lên như là yếu tố dự đoán độc lập về tiến triển của bệnh thận trong đái tháo đường tuýp 1, với dân tộc Phi-Caribbean là yếu tố nguy cơ chính https://news.medxy.ai/blood-pressure-variability-kidney-disease-kidney-disease/Medxy AIen2026-04-05T15:11:42-07:00Blood Pressure Variability Emerges as Independent Predictor of Kidney Disease Progression in Type 1 Diabetes, with African Caribbean Ethnicity as Key Risk Factor https://news.medxy.ai/zh/decoding-heart-failure-peptides/Medxy AIzh2026-04-05T14:44:49-07:00解码心力衰竭肽组：横断面研究揭示新型生物标志物和患者群 https://news.medxy.ai/ja/heart-failure-peptidome-discovery/Medxy AIja2026-04-05T14:43:31-07:00心不全ペプチドオームの解読：横断的研究で新たなバイオマーカーと患者クラスターを発見 https://news.medxy.ai/vi/peptidome-heart-failure/Medxy AIvi2026-04-05T14:41:31-07:00Giải mã Peptidome trong suy tim: Một nghiên cứu ngang cắt tiết lộ các dấu hiệu sinh học mới và nhóm bệnh nhân https://news.medxy.ai/zh/heart-failure-veterans-therapy/Medxy AIzh2026-04-05T14:39:00-07:00仅1/5的心力衰竭退伍军人在3年内实现推荐的四联疗法——这对临床实践的意义 https://news.medxy.ai/heart-failure-biomarkers/Medxy AIen2026-04-05T14:38:29-07:00Decoding the Heart Failure Peptidome: A Cross-Sectional Study Uncovers Novel Biomarkers and Patient Clusters https://news.medxy.ai/ja/heart-failure-treatment-study/Medxy AIja2026-04-05T14:36:50-07:00心不全患者のうち、3年以内に推奨される4剤併用療法を達成したのは5人に1人だけ—臨床実践への影響 https://news.medxy.ai/vi/one-in-five-veterans-heart-failure-treatment/Medxy AIvi2026-04-05T14:34:40-07:00Chỉ 1 trong 5 cựu chiến binh mắc suy tim đạt liệu pháp bốn thuốc theo khuyến nghị trong vòng 3 năm—Ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/veterans-heart-failure-therapy/Medxy AIen2026-04-05T14:28:56-07:00Only 1 in 5 Veterans with Heart Failure Achieve Recommended Quadruple Therapy Within 3 Years—What This Means for Clinical Practice https://news.medxy.ai/zh/pulse-field-ablation-safety/Medxy AIzh2026-04-05T14:23:50-07:00脉冲场消融在疗效上与射频消融相当，但对阵发性心房颤动的安全性更高：BEAT PAROX-AF试验 https://news.medxy.ai/ja/pulse-field-ablation-af/Medxy AIja2026-04-05T14:22:33-07:00パルスフィールドアブレーションは、頻発性心房細動に対する電気透熱アブレーションと同等の効果を示し、安全性が優れている：BEAT PAROX-AF試験 https://news.medxy.ai/vi/electrical-pulse-destruction/Medxy AIvi2026-04-05T14:20:26-07:00Phá hủy bằng trường điện xung đạt hiệu quả tương đương với phá hủy bằng tần số vô tuyến cho rung nhĩ cơn: Thử nghiệm BEAT PAROX-AF https://news.medxy.ai/pulsed-field-ablation-safety/Medxy AIen2026-04-05T14:17:32-07:00Pulsed Field Ablation Matches Radiofrequency in Efficacy but Shows Superior Safety Profile for Paroxysmal Atrial Fibrillation: BEAT PAROX-AF Trial https://news.medxy.ai/zh/redefining-raas-axis/Medxy AIzh2026-04-05T05:50:03-07:00重新定义肾素-醛固酮轴：从分类诊断到连续的心肾风险谱 https://news.medxy.ai/ja/aldosterone-axis-redefined/Medxy AIja2026-04-05T05:48:32-07:00ルエンイン-アルドステロン軸の再定義：カテゴリー診断から持続的な心腎リスクスペクトラムへ https://news.medxy.ai/vi/renin-aldosterone-axis/Medxy AIvi2026-04-05T05:46:01-07:00Định nghĩa lại trục Renin-Aldosterone: Từ chẩn đoán phân loại đến phổ liên tục nguy cơ tim thận https://news.medxy.ai/redefining-renin-aldosterone-axis/Medxy AIen2026-04-05T05:42:28-07:00Redefining the Renin-Aldosterone Axis: From Categorical Diagnosis to a Continuous Spectrum of Cardiorenal Risk https://news.medxy.ai/zh/adaptive-ai-cardiovascular-decision/Medxy AIzh2026-04-05T05:14:20-07:00自适应AI变革心血管事件裁决：新算法在多个终点上实现接近人类的准确性 https://news.medxy.ai/ja/adaptive-ai-cardiovascular-evaluation/Medxy AIja2026-04-05T05:12:38-07:00適応型AIが心血管イベント評価を変革：新アルゴリズムが複数のエンドポイントで人間と同等の精度を達成 https://news.medxy.ai/vi/adaptive-ai-cardiac-evaluation/Medxy AIvi2026-04-05T05:09:41-07:00Trí tuệ nhân tạo thích ứng biến đổi việc đánh giá sự kiện tim mạch: Thuật toán mới đạt độ chính xác gần bằng con người trên nhiều điểm cuối https://news.medxy.ai/adaptive-ai-cardiovascular-adjudication/Medxy AIen2026-04-05T05:05:41-07:00Adaptive AI Transforms Cardiovascular Event Adjudication: New Algorithm Achieves Near-Human Accuracy Across Multiple Endpoints